Answers are grounded in this paper and cite their sources.
Demonstrates a novel treatment for Parkinson's disease by utilizing non-invasive nanotherapy to cross the blood-brain barrier, suggesting new therapeutic possibilities.
This study synthesizes ZnO@PDA as a non-invasive platform for Parkinson's disease treatment. They utilize photothermal effects to open the blood–brain barrier, enable ultrasound-triggered neuronal stimulation, and provide antioxidant therapy.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: